NCT06769087Enrolling by invitation
Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery
Comparative Analysis of Clinical and Patient-Reported Outcomes: Immediate Versus Postoperative Day 1 Removal of Urinary Catheter After Colorectal Cancer Surgery in a Non-inferiority, Randomized Controlled Trial.
Source: ClinicalTrials.gov · Last updated 9 Jul 2026
Brief summary (registry, in English)
The enhanced recovery after surgery (ERAS) program is widely applied in colorectal cancer surgery. Among the early recovery programs after surgery, the timing of removal of the urinary catheter after surgery has been emphasized recently, but the specific timing is still under discussion. Maintaining the urinary catheter after surgery is to prevent urinary retention after surgery, but it is known that the risk of urinary tract infection increases the longer it is maintained. Previously, it was removed 3 days after colorectal cancer surgery, but several studies reported that even if it was removed earlier, the incidence of urinary retention did not increase, and rather the incidence of urinary tract infection decreased. In particular, by applying the early recovery program after surgery, factors related to patient recovery before, during, and after surgery are applied to help rapid recovery, and it has been reported that early removal of the urinary catheter has a positive effect on postoperative recovery and complications. Therefore, it is necessary to prove that the timing of removal of the urinary catheter after surgery in colorectal cancer patients can help early recovery through clinical results such as patient recovery and occurrence of complications.
- Status (registry)
- Enrolling by invitation
- Study type
- Interventional
- Enrollment
- 316 (estimated)
- First submitted
- 30 Dec 2024
- Start date
- 1 Dec 2024
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Seoul St. Mary's Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06769087
What you commit to
- Study type: Interventional
- Planned participants: 316
- From 1 Dec 2024 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients who have undergone conventional treatment in cases other than distant metastasis or R0 resection
- Patients who have developed complications related to the urinary system during surgery and require maintenance of a urinary catheter such as a urethral stent
- Patients who have undergone urinary surgery such as urethral stent placement, cystectomy, or urostomy in the past
Other illness
- Patients who require continuous monitoring through a urinary catheter due to hemodynamic instability or massive bleeding, etc.
- Patients who are on hemodialysis or peritoneal dialysis due to chronic renal failure
Other
- Patients who have undergone two or more major abdominal surgeries, including lateral pelvic lymph node dissection, at the same time
- Patients who cannot participate in a clinical trial at the discretion of a physician
- Patients who do not wish to participate in the study
Who the study is looking for
- 19 years old 80 years old
- Patients diagnosed with colorectal cancer who are eligible for radical resection surgery
- Patients who underwent open, laparoscopic, or robotic surgery
- Written informed consent
Age in the registry: 19 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Seoul St. Mary's Hospital, The Catholic University of Korea Coordinator of this site? Confirm its status | Seoul | South Korea | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.